369403-24-7

Basic information

• Product Name: 1,4-Dioxaspiro[4.5]decane-8-carboxylicacid,8-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-(9CI)
• Synonyms: 1,4-Dioxaspiro[4.5]decane-8-carboxylicacid,8-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-(9CI);8-(FMoc-aMino)-1,4-dioxaspiro[4.5]decane-8-carboxylic Acid;8-(9H-Fluoren-9-ylmethoxycarbonylamino)-1,4-dioxa-spiro[4.5]decane-8-carboxylic
• CAS NO: 369403-24-7
• Molecular Formula: C₂₄H₂₅NO₆
• Molecular Weight: 423.4584
• Product Categories: FMOC
• Mol File: 369403-24-7.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1,4-Dioxaspiro[4.5]decane-8-carboxylicacid,8-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 1,4-Dioxaspiro[4.5]decane-8-carboxylicacid,8-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-(9CI)(369403-24-7)
• EPA Substance Registry System: 1,4-Dioxaspiro[4.5]decane-8-carboxylicacid,8-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-(9CI)(369403-24-7)

Safety Data

• Hazardous Substances Data: 369403-24-7(Hazardous Substances Data)

Usage

Uses

8-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]-1,4-dioxaspiro[4.5]decane-8-carboxylic acid

Upstream product

• 54621-17-9 9,12-dioxa-2,4-diazadispiro[4.2.4^Λ{8}.2^Λ{5}]tetradecane-1,3-dione 
• 4746-97-8 cyclohexanedione monoethylene ketal 
• 54621-18-0 8-amino-1,4-dioxa-spiro[4.5]decane-8-carboxylic acid 
• 82911-69-1 N-(9H-fluoren-2-ylmethoxycarbonyloxy)succinimide 

Downstream Products

• 1398718-50-7 (S)-(9H-fluoren-9-yl)methyl 8-(1-cyano-2-(4'-((4-methylpiperazin-1-yl)methyl)biphenyl-4-yl)ethylcarbamoyl)-1,4-dioxaspiro[4.5]decan-8-ylcarbamate 
• 1398717-87-7 (S)-8-amino-N-(1-cyano-2-(4'-((4-methylpiperazin-1-yl)methyl)biphenyl-4-yl)ethyl)-1,4-dioxaspiro[4.5]decane-8-carboxamide 
• 729593-19-5 3-[3-(2,6-diisopropyl-phenyl)-ureido]-6-methoxy-2,3,4,9-tetrahydro-1H-carbazole-3-carboxylic acid (1-pyridin-2-yl-cyclohexylmethyl)-amide 

Relevant articles and documents

PEPTIDYL NITRILCOMPOUNDS AS PEPTIDASE INHIBITORS

The invention relates to compounds of Formula (II) and their use in theraphy as peptidase inhibitors.

Tetrahydrocarbazol derivatives as ligands for G-protein-coupled receptors (GPCR)

This invention provides new tetrahydrocarbazole derivatives that act as ligands for G-protein-coupled receptors (GPCR), especially as antagonists of the gonadotropin-releasing hormone (GnRH). A pharmaceutical composition that contains these new tetrahydro